Medication-Related Osteonecrosis of the Jaw (MRONJ) is a growing concern in dental and medical care, particularly among patients undergoing certain systemic therapies. The condition is often triggered by invasive dental procedures and is influenced by the type and duration of medications used. Preventive dental assessments, coordinated treatment planning, and patient education play essential roles in minimizing risk. As awareness increases, clinical strategies continue to evolve to ensure safer outcomes for individuals at risk.
Here is a quick question about MRONJ risk in dental patients! Reference : Brazilian Journal of Oral Science ##Disclaimer## The content provided on Docplexus is intended for educational purposes only. While we strive to ensure its accuracy, we make no warranties, explicit or implied, about the suitability, reliability, or adequacy of the information, including…
